Maximus, Inc. (NYSE:MMS) – Stock analysts at First Analysis upped their Q1 2018 earnings per share estimates for shares of Maximus in a research report issued to clients and investors on Sunday. First Analysis analyst F. Sparacino now anticipates that the health services provider will earn $0.78 per share for the quarter, up from their prior estimate of $0.77. First Analysis also issued estimates for Maximus’ Q2 2018 earnings at $0.75 EPS, Q3 2018 earnings at $0.71 EPS, Q4 2018 earnings at $0.76 EPS, FY2018 earnings at $3.00 EPS and FY2019 earnings at $3.31 EPS.

ILLEGAL ACTIVITY WARNING: This article was reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/11/15/q1-2018-eps-estimates-for-maximus-inc-boosted-by-analyst-mms.html.

Other equities analysts have also issued reports about the stock. Zacks Investment Research lowered shares of Maximus from a “hold” rating to a “sell” rating in a research report on Tuesday. BidaskClub lowered shares of Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Robert W. Baird restated a “hold” rating and issued a $64.00 price objective on shares of Maximus in a research report on Friday, September 1st. Maxim Group set a $66.00 price objective on shares of Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. Finally, Canaccord Genuity cut their price objective on shares of Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research report on Friday, November 10th. Two research analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. Maximus currently has an average rating of “Hold” and an average price target of $63.00.

Maximus (NYSE:MMS) traded up $0.20 during mid-day trading on Tuesday, hitting $64.78. 285,200 shares of the stock were exchanged, compared to its average volume of 363,109. Maximus has a one year low of $51.74 and a one year high of $66.96. The company has a market capitalization of $4,189.45, a price-to-earnings ratio of 20.78, a P/E/G ratio of 2.06 and a beta of 1.32.

Hedge funds have recently bought and sold shares of the business. State of Tennessee Treasury Department raised its stake in shares of Maximus by 50.0% during the second quarter. State of Tennessee Treasury Department now owns 60,000 shares of the health services provider’s stock worth $3,758,000 after acquiring an additional 20,000 shares in the last quarter. Koch Industries Inc. purchased a new position in shares of Maximus during the second quarter worth approximately $629,000. Mutual of America Capital Management LLC raised its stake in shares of Maximus by 26.6% during the second quarter. Mutual of America Capital Management LLC now owns 108,053 shares of the health services provider’s stock worth $6,767,000 after acquiring an additional 22,713 shares in the last quarter. Virginia Retirement Systems ET AL raised its stake in shares of Maximus by 3.5% during the second quarter. Virginia Retirement Systems ET AL now owns 46,700 shares of the health services provider’s stock worth $2,925,000 after acquiring an additional 1,600 shares in the last quarter. Finally, Van Berkom & Associates Inc. raised its stake in shares of Maximus by 4.5% during the second quarter. Van Berkom & Associates Inc. now owns 1,150,713 shares of the health services provider’s stock worth $72,069,000 after acquiring an additional 49,360 shares in the last quarter. 97.55% of the stock is currently owned by hedge funds and other institutional investors.

In other Maximus news, CEO Richard A. Montoni sold 29,203 shares of Maximus stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the sale, the chief executive officer now directly owns 549,215 shares in the company, valued at $33,161,601.70. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel David Francis sold 2,000 shares of Maximus stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $58.89, for a total transaction of $117,780.00. Following the sale, the general counsel now owns 13,716 shares of the company’s stock, valued at $807,735.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 104,103 shares of company stock valued at $6,509,460. 3.10% of the stock is currently owned by company insiders.

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be given a dividend of $0.045 per share. The ex-dividend date is Tuesday, November 14th. This represents a $0.18 annualized dividend and a yield of 0.28%. Maximus’s payout ratio is presently 5.66%.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Earnings History and Estimates for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.